Vanguard Tl Intl Bnd (BNDX) 55.03 $BNDX 15 Most Read ETF

Innovative Payments with AI Power Alright, folks, Rain's gone and done something that's probably going to shake things up in the payments world—'cause they've given AI agents the ability to handle money like never before. We're not just talking about some run-of-the-mill integration here. This is a genuine game changer, promising to make agents as financially savvy as...

Deal or No Deal: ProBio's New Licensing Agreement In the ever-evolving realm of biopharmaceuticals, ProBio's recent handshake with South Korea's AbTis is stirring the pot. The shot-callers at ProBio are passing the baton to AbTis, giving them a crack at developing a thumping new therapeutic antibody asset aimed squarely at oncology targets. Pretty slick move if you ask...

Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Weaving a Web of Connectivity Let's talk about FirstDigital putting its shoulder to the wheel in Utah and Arizona. They're expanding their redundant fiber network to rope in more businesses under their umbrella of connectivity. This ain't just another dry IT endeavor—it's about building a safety net for our ever-connected world. The Stakes of Network Disruption You know...

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Evening Darkness and Safety Concerns Folks, it seems Bakersfield streets transform into a battlefield once the clock falls back. With darkness creeping in earlier, those evening hours right after the time change see a sobering uptick in accidents. According to an analysis by Chain | Cohn | Clark, pedestrian and bicyclist crashes from 5 to 7 p.m. double. It's not just...

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

An Artist in the Kitchen Who knew a kitchen hood could be a canvas, right? Zephyr, always a punch above the ordinary in kitchen design, has pulled another rabbit out of their hat with the Alto Wall Custom Hood. Forget blending in; this piece is about standing out and shouting style—all while keeping your cooking area fresh. Options Galore The Alto Hood isn't about...

Constellation Brands Sets New Reporting Date Constellation Brands, Inc. (NYSE: STZ), a prominent player in the beverage alcohol sector, has recently revised its reporting schedule for the financial results of its second quarter, which ended on August 31, 2025. The new reporting date is set for October 6, 2025, after the markets close. Investors and analysts will be able...

Analyzing the Recent Options Trends of Charter Communications The options market is bustling with activity around Charter Communications, indicating a strong bullish sentiment. Investors with significant capital are positioning themselves favorably, potentially anticipating upward price movements for the stock, CHTR. Summary of Options Trading Activity Examining the...

California Water Service Group Advances Sustainability Initiatives In its latest report, California Water Service Group (NYSE: CWT) has unveiled significant progress on various sustainability efforts aimed at minimizing its environmental footprint and enhancing corporate responsibility. This comprehensive overview showcases the Group's dedication to maintaining high...

Important Deadline for Outset Medical Investors Investors, it’s time to stay alert! There’s an upcoming deadline that you need to be aware of regarding the class action lawsuit against Outset Medical, Inc. This lawsuit concerns investors who purchased or acquired securities of Outset Medical during a specific period. With the deadline looming, many individuals may be...

Investors' Alert: Class Action Against ASML Holding N.V. ASML Holding N.V. (NASDAQ: ASML) is currently facing a class action securities lawsuit that aims to defend the interests of its investors who may have suffered financial losses. This legal move is significant, especially for those who have been adversely affected by certain events within the semiconductor industry....